99% Savings - Buy Just @1 Rs X
Ergagin 0.125 Injection is a prescription drug, available for use as Injection. Post Delivery Bleeding are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Ergagin 0.125 Injection. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Ergagin 0.125 Injection include Headache, Abdominal Pain, Hypertension. Apart from the aforementioned side effects, Ergagin 0.125 Injection can also lead to other problems, which have been listed below. Such side effects of Ergagin 0.125 Injection normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Ergagin 0.125 Injection's effect is Unknown during pregnancy and Unknown for lactating mothers. In addition, Ergagin 0.125 Injection's effects on the liver, heart and kidney are discussed below in the Ergagin 0.125 Injection related warnings section.
Ergagin 0.125 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. High Blood Pressure are examples of such conditions. Other conditions have been mentioned below in the Ergagin 0.125 Injection contraindications section.
Drug reaction of Ergagin 0.125 Injection with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Ergagin 0.125 Injection is considered safe while driving, and is addictive.
Ergagin 0.125 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Is the use of Ergagin 0.125 Injection safe for pregnant women?
Side effects of Ergagin during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Ergagin 0.125 Injection safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Ergagin for breastfeeding women are not known.
What is the effect of Ergagin 0.125 Injection on the Kidneys?
Ergagin may have mild side effects on the kidneys.
What is the effect of Ergagin 0.125 Injection on the Liver?
Ergagin may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Ergagin 0.125 Injection on the Heart?
Use of Ergagin may be dangerous for the heart. Do not use it without doctor's advice.
If you are suffering from any of the following diseases, you should not take Ergagin 0.125 Injection unless your doctor advises you to do so -
Is this Ergagin 0.125 Injection habit forming or addictive?
Ergagin 0.125 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Ergagin 0.125 Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Ergagin 0.125 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Ergagin 0.125 Injection for mental disorders.
Interaction between Food and Ergagin 0.125 Injection
There is no information on the effects of taking Ergagin 0.125 Injection with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Ergagin 0.125 Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Ergagin 0.125 Injection with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839